公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Mouse Models for Immunotherapy in Hepatocellular Carcinoma | OU, DA-LIANG; Lin, Li; Chen, Chia-Wei; DA-LIANG OU | Cancers | 21 | 20 | |
2011 | Optimization of Culture Condition for ACEI and GABA Production by Lactic Acid Bacteria | Tung, YT; Ou, Da-Liang; TZU-MING PAN ; Tung, Yi-Ting; Chang, Chun-Jung; Lee, BH; Lee, Bao-Hong; Liu, CF; Jeng, Yung-Ming; Liu, Chin-Feng; Lin, Yi-Jang; Pan, Tzu-Ming ; Pan, TM.; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 | Journal of Food Science | 32 | 26 | |
2024 | A potential novel cancer immunotherapy: Agonistic anti-CD40 antibodies | Jian, Cheng-Zhe; Lin, Li; Hsu, Chia-Lang; Chen, Yu-Hsin; CHIUN HSU ; Tan, Ching-Ting; Ou, Da-Liang | Drug discovery today | |||
2013 | Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model. | Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 鄭安理 | Cancer Res. | 0 | 0 |